Koletar, S L <br/><br/>
A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l.  [electronic resource] 

 -  AIDS (London, England)  Aug 2001 
 - 1509-15 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0269-9370 
<br/><br/><label>Standard No.: </label>10.1097/00002030-200108170-00008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS-Related Opportunistic Infections--prevention & control<br/>Adult<br/>Anti-HIV Agents--therapeutic use<br/>Antifungal Agents--administration & dosage<br/>CD4 Lymphocyte Count<br/>Female<br/>HIV Infections--complications<br/>Humans<br/>Male<br/>Pneumonia, Pneumocystis--prevention & control<br/>Prospective Studies